GUYASUTA INVESTMENT ADVISORS INC - PEREGRINE PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
GUYASUTA INVESTMENT ADVISORS INC ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$7,000
-66.7%
18,5400.0%0.00%
-66.7%
Q4 2015$21,000
+50.0%
18,540
+27.5%
0.00%
+50.0%
Q3 2015$14,000
-26.3%
14,5400.0%0.00%
-33.3%
Q2 2015$19,0000.0%14,5400.0%0.00%0.0%
Q1 2015$19,000
-5.0%
14,5400.0%0.00%0.0%
Q4 2014$20,000
+5.3%
14,5400.0%0.00%0.0%
Q3 2014$19,000
-29.6%
14,5400.0%0.00%
-25.0%
Q2 2014$27,0000.0%14,5400.0%0.00%0.0%
Q1 2014$27,000
+35.0%
14,5400.0%0.00%
+33.3%
Q4 2013$20,0000.0%14,5400.0%0.00%0.0%
Q3 2013$20,000
+11.1%
14,5400.0%0.00%0.0%
Q2 2013$18,00014,5400.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
BAXTER BROS INC 148,006$206,0000.10%
First Heartland Consultants, Inc. 86,204$120,0000.07%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 671,900$934,0000.02%
Investors Capital Advisory Services 47,238$65,0000.02%
PINNACLE FINANCIAL PARTNERS INC 20,000$28,0000.01%
Commonwealth Equity Services, Inc 481,140$669,0000.01%
REYNOLDS CAPITAL MANAGEMENT LLC 11,300$16,0000.01%
First Allied Advisory Services, Inc. 50,000$70,0000.01%
Winslow, Evans & Crocker, Inc. 13,200$18,0000.01%
AMALGAMATED BANK 16,650$23,0000.00%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders